David Schuster, MD, FACR

Role

Nuclear Medicine
Specialty

Breast Cancer Neuroendocrine Tumors Prostate Cancer
Research Program

Discovery and Developmental Therapeutics
Practicing Since

1992

Background

Dr. Schuster is Director of the Division of Nuclear Medicine and Molecular Imaging and is a Georgia Research Alliance Distinguished Scientist. He serves in an NIH study section and reviews for medical journals. Dr. Schuster is widely published and has lectured nationally and internationally. Dr. Schuster is the recipient of the Society of Nuclear Medicine Tetalman Award and is also known for his co-authorship of the book “A Clinician’s Guide to Nuclear Medicine”.

Titles & Roles

Professor, Department of Radiology and Imaging Sciences

Emory University School of Medicine
Director, Division of Nuclear Medicine and Molecular Imaging

Emory University School of Medicine

Education & Training

Education

Fellowship, Nuclear Medicine, 1997
Emory University School of Medicine
Residency, Radiology, 1992
Tufts - New England Medical Center
Internship, Medical Internship, 1988
Albany Medical Center Hospital
Medical Education, MD, 1987
Albany Medical Center Hospital

Board Certifications

Nuclear Medicine
American Board of Nuclear Medicine, 1997
Nuclear Radiology
American Board of Radiology, 1997
Diagnostic Radiology
American Board of Radiology, 1992

Professional Memberships

American Roentgen Ray Society
Radiological Society of North America
Society of Nuclear Medicine

Research

View Current Clinical Trials


Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients Phase I Conditions MRI Scan Location Winship Cancer Institute
Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients with Biochemically Recurrent Prostate Cancer Phase I Conditions Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Location Winship Cancer Institute

Grants

View Grants

Grant Number	Title
5K12CA237806-05	Emory Clinical Oncology Career Development Award K12 Program
5R01CA226992-05	Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes

Publications

Title/Journal	Authors	Publication Date
PPV of Bone Uptake of ¹⁸F-Flotufolastat: Evaluation Using SPOTLIGHT Study Data. AJR. American journal of roentgenology	DM Schuster, AB Jani, CV Marcus, A Chau, P Davis	11/01/2024
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinoma. European journal of nuclear medicine and molecular imaging	A Mushtaq, IO Lawal, S Muzahir, SC Friend, M Bhave, JL Meisel, MA Torres, TM Styblo, CL Graham, K Kalinsky, J Switchenko, GA Ulaner, DM Schuster	11/01/2024
[⁸⁹Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. The Lancet. Oncology	B Shuch, AJ Pantuck, JC Bernhard, MA Morris, V Master, AM Scott, C van Praet, C Bailly, B Önal, T Aksoy, R Merkx, DM Schuster, ST Lee, N Pandit-Taskar, AC Fan, P Allman, K Schmidt, L Tauchmanova, M Wheatcroft, C Behrenbruch, CRW Hayward, P Mulders	10/01/2024
¹⁸F-Flotufolastat Positron Emission Tomography in African American Patients With Suspected Prostate Cancer Recurrence: Findings From the Phase 3 SPOTLIGHT Study. Advances in radiation oncology	S Rais-Bahrami, M Fleming, B Gartrell, WC Lavely, A Chau, P Davis, DM Schuster	09/01/2024
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study. Clinical nuclear medicine	N Kokabi, LA Webster, H Dabbous, A Shah, D Brandon, J Galt, M Xing, A Villalobos, A Davarpanahfakhr, SC Kappadath, DM Schuster	09/01/2024
Impact of Clinical Factors on ¹⁸F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study. Advances in radiation oncology	BH Lowentritt, AB Jani, BT Helfand, EM Uchio, MA Morris, JM Michalski, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2024
Interreader and Intrareader Reproducibility of ¹⁸F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	PH Kuo, G Esposito, GA Ulaner, D Yoo, K Zukotynski, GC Ravizzini, R Penny, MP Miller, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2024
True-Positive ¹⁸F-Flotufolastat Lesions in Patients with Prostate Cancer Recurrence with Baseline-Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter SPOTLIGHT Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	MT Fleming, R Hermsen, AS Purysko, A Chau, P Davis, BF Chapin, DM Schuster	07/01/2024
Biochemical Relapse-Free Survival in Postprostatectomy Patients Receiving 18F-Fluciclovine-Guided Prostate Bed-Only Radiation: Post Hoc Analysis of a Prospective Randomized Trial. Practical radiation oncology	VR Dhere, DM Schuster, S Goyal, E Schreibmann, BW Hershatter, SA Patel, JW Shelton, S Hanasoge, PR Patel, NT Sebastian, OA Adediran, IO Lawal, AB Jani	01/01/2024
Prostate Cancer Skeletal Metastasis: A Spontaneous Evolution from Osteolytic to Osteoblastic Morphology without Treatment. World journal of nuclear medicine	IO Lawal, MA Bilen, RK Halkar, AB Jani, DM Schuster	12/01/2023
Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. Cancers	CS Moreno, CL Winham, M Alemozaffar, ER Klein, IO Lawal, OA Abiodun-Ojo, D Patil, BG Barwick, Y Huang, DM Schuster, MG Sanda, AO Osunkoya	11/30/2023
Diagnostic Performance and Safety of Positron Emission Tomography with ¹⁸F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE). European urology	DS Surasi, M Eiber, T Maurer, MA Preston, BT Helfand, D Josephson, AK Tewari, DM Somford, S Rais-Bahrami, BF Koontz, PJ Bostrom, A Chau, P Davis, DM Schuster, BF Chapin	10/01/2023
Biochemical Relapse-Free Survival in Post-Prostatectomy Patients Receiving ¹⁸F-Fluciclovine-Guided Prostate Bed Only Radiation: Post-Hoc Analysis of a Prospective Randomized Trial. International journal of radiation oncology, biology, physics	VR Dhere, DM Schuster, S Goyal, E Schreibmann, B Hershatter, SA Patel, JW Shelton, S Hanasoge, PR Patel, N Sebastian, IO Lawal, A Jani	10/01/2023
Evaluation of Treatment Response in Patients with Breast Cancer. PET clinics	S Muzahir, GA Ulaner, DM Schuster	10/01/2023
Aberrant Vascular Anatomy Associated With Artifactual Focal Avidity in the Liver on PSMA PET. Clinical nuclear medicine	IO Lawal, M Pectasides, AS Parihar, HU Shah, RK Halkar, AB Jani, DM Schuster	09/01/2023
Stronger Together-Collaboration Will Only Enhance Patient Care. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	EE Grady, DA Mankoff, DM Schuster	09/01/2023
Diagnostic Performance and Safety of ¹⁸F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply. The Journal of urology	AB Jani, GC Ravizzini, BA Gartrell, BA Siegel, P Twardowski, D Saltzstein, MT Fleming, A Chau, P Davis, BF Chapin, DM Schuster	09/01/2023
Diagnostic Performance and Safety of ¹⁸F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). The Journal of urology	AB Jani, GC Ravizzini, BA Gartrell, BA Siegel, P Twardowski, D Saltzstein, MT Fleming, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2023
Reply by Authors. The Journal of urology	AB Jani, GC Ravizzini, BA Gartrell, BA Siegel, P Twardowski, D Saltzstein, MT Fleming, A Chau, P Davis, BF Chapin, DM Schuster	08/01/2023
Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study. European journal of nuclear medicine and molecular imaging	N Kokabi, L Arndt-Webster, B Chen, D Brandon, I Sethi, A Davarpanahfakhr, J Galt, M Elsayed, Z Bercu, M Cristescu, SC Kappadath, DM Schuster	05/01/2023
ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update. Journal of the American College of Radiology : JACR	B Turkbey, A Oto, BC Allen, O Akin, LF Alexander, M Ari, AT Froemming, PF Fulgham, LM Gettle, JK Maranchie, SA Rosenthal, N Schieda, DM Schuster, AM Venkatesan, ME Lockhart	05/01/2023
A Discordant Pattern of Uptake on 68 Ga-PSMA PET/CT Versus 18 F-Fluciclovine PET/CT in Radiation-Induced Hepatitis : Implications for Early Postradiotherapy Imaging-Based Response Assessment. Clinical nuclear medicine	OA Adediran, IO Lawal, S Muzahir, MA Bhave, S Friend, B Fielder, J Meisel, MA Torres, TM Styblo, C Graham, A Holbrook, K Kalinsky, RJ Crowe, GA Ulaner, DM Schuster	04/01/2023
Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy. Clinical nuclear medicine	IO Lawal, C Marcus, DM Schuster, S Goyal, OA Adediran, VR Dhere, SS Joshi, OA Abiodun-Ojo, VA Master, PR Patel, B Fielder, M Goodman, JW Shelton, O Kucuk, B Hershatter, RK Halkar, AB Jani	04/01/2023
Treatment Response to Lycopene in Recurrent Prostate Cancer Confirmed on 18 F-Fluciclovine PET/CT. Clinical nuclear medicine	C Wu, C Marcus, Y Baum, O Kucuk, DM Schuster	04/01/2023
Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	IO Lawal, AB Jani, OA Adediran, S Goyal, OA Abiodun-Ojo, VR Dhere, CV Marcus, SS Joshi, VA Master, PR Patel, M Goodman, JW Shelton, O Kucuk, B Hershatter, B Fielder, RK Halkar, DM Schuster	04/01/2023
Correlation of Non-tumoral Liver Dose with Treatment-Related Adverse Events in Patients with Hepatocellular Carcinoma Treated with Glass-Based Yttrium-90 Radioembolization. Cardiovascular and interventional radiology	LA Webster, A Villalobos, B Cheng, M Xing, BS Majdalany, ZL Bercu, MM Cristescu, D Brandon, D Schuster, Y Baum, MF Loya, N Kokabi	01/01/2023
A Tale of 3 Tracers: Contrasting Uptake Patterns of 18F-Fluciclovine, 68Ga-PSMA, and 18F-FDG in the Uterus and Adnexa. Clinical nuclear medicine	IO Lawal, OA Adediran, S Muzahir, S Friend, MA Bhave, J Meisel, MA Torres, TM Styblo, C Graham, A Holbrook, K Kalinsky, B Fielder, RJ Crowe, GA Ulaner, DM Schuster	01/01/2023
Lesion segmentation on ¹⁸F-fluciclovine PET/CT images using deep learning. Frontiers in oncology	T Wang, Y Lei, E Schreibmann, J Roper, T Liu, DM Schuster, AB Jani, X Yang	01/01/2023
Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [⁶⁸Ga]Ga DOTATATE PET-CT. Cancers	MA Bilen, A Akintayo, Y Liu, O Abiodun-Ojo, O Kucuk, BC Carthon, DM Schuster, EE Parent	12/08/2022
Accuracy and Safety of Scout Dose Resin Yttrium-90 Microspheres for Radioembolization Therapy Treatment Planning: A Prospective Single-Arm Clinical Trial. Journal of vascular and interventional radiology : JVIR	N Kokabi, LA Webster, M Elsayed, JM Switchenko, B Chen, D Brandon, J Galt, I Sethi, M Cristescu, SC Kappadath, DM Schuster	12/01/2022
18F-Fluciclovine PET/CT: A Potential Imaging Biomarker for the Evaluation of Multiple Myeloma. Clinical nuclear medicine	C Marcus, DM Schuster, SH Tajmir	09/01/2022
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (¹⁸F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects. International journal of radiation oncology, biology, physics	VR Dhere, DM Schuster, S Goyal, E Schreibmann, BW Hershatter, PJ Rossi, JW Shelton, PR Patel, AB Jani	08/01/2022
MRI-based prostate and dominant lesion segmentation using cascaded scoring convolutional neural network. Medical physics	ZA Eidex, T Wang, Y Lei, M Axente, OO Akin-Akintayo, OAA Ojo, AA Akintayo, J Roper, JD Bradley, T Liu, DM Schuster, X Yang	08/01/2022
ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 Update. Journal of the American College of Radiology : JACR	N Schieda, A Oto, BC Allen, O Akin, SJ Barker, PF Fulgham, LM Gettle, JK Maranchie, BN Patel, DM Schuster, D Smith, IB Turkbey, ME Lockhart	05/01/2022
Predictors and Real-World Use of Prostate-Specific Radioligand Therapy: PSMA and Beyond. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting	A Gafita, C Marcus, L Kostos, DM Schuster, J Calais, MS Hofman	04/01/2022
Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT. Clinical nuclear medicine	C Marcus, K Baugnon, DM Schuster	03/01/2022
82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...	EE Parent, I Sethi, J Nye, C Holder, JJ Olson, J Switchenko, F Tade, OO Akin-Akintayo, OA Abiodun-Ojo, A Akintayo, DM Schuster	03/01/2022
Prostate and dominant intraprostatic lesion segmentation on PET/CT using cascaded regional-net. Physics in medicine and biology	LA Matkovic, T Wang, Y Lei, OO Akin-Akintayo, OA Abiodun Ojo, AA Akintayo, J Roper, JD Bradley, T Liu, DM Schuster, X Yang	12/07/2021
Improved Tumor Response in Patients on Metformin Undergoing Yttrium-90 Radioembolization Segmentectomy for Hepatocellular Carcinoma. Cardiovascular and interventional radiology	M Elsayed, W Wagstaff, K Behbahani, A Villalobos, Z Bercu, BS Majdalany, M Akce, DM Schuster, H Mao, N Kokabi	12/01/2021
¹⁸F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review. Prostate cancer and prostatic diseases	S Rais-Bahrami, JA Efstathiou, CM Turnbull, SB Camper, A Kenwright, DM Schuster, AF Scarsbrook	12/01/2021
Role of Resin Microsphere Y90 Dosimetry in Predicting Objective Tumor Response, Survival and Treatment Related Toxicity in Surgically Unresectable Colorectal Liver Metastasis: A Retrospective Single Institution Study. Cancers	T Sankhla, B Cheng, N Nezami, M Xing, I Sethi, Z Bercu, D Brandon, B Majdalany, DM Schuster, N Kokabi	09/29/2021
PET Imaging for Prostate Cancer. Radiologic clinics of North America	B Savir-Baruch, RA Werner, SP Rowe, DM Schuster	09/01/2021
Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization. Cardiovascular and interventional radiology	B Cheng, A Villalobos, I Sethi, W Wagstaff, J Galt, D Brandon, DM Schuster, Z Bercu, B Majdalany, N Kokabi	08/01/2021
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on ¹⁸F-Fluciclovine PET/CT Guidance. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AB Jani, AA Akintayo, OO Akin-Akintayo, OA Odewole, FI Tade, SS Joshi, VA Master, B Fielder, RK Halkar, C Zhang, S Goyal, MM Goodman, DM Schuster	08/01/2021
Determination of tumour dose response threshold and implication on survival in patients with HCC treated with Y90 radiation segmentectomy: a simple semi-quantitative analysis. Nuclear medicine communications	B Cheng, I Sethi, A Villalobos, W Wagstaff, DM Schuster, Z Bercu, D Brandon, N Kokabi	08/01/2021
Optimal Management of the Hyperkinetic Gallbladder: A Comparison of Outcomes Between Operative and Nonoperative Approaches. The American surgeon	ML Williford, KT Fay, FJ Simpson, AM Defnet, DM Schuster, I Sethi, E Lin, SS Davis	06/01/2021
¹⁸F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial. Lancet (London, England)	AB Jani, E Schreibmann, S Goyal, R Halkar, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, VA Master, SS Joshi, O Kucuk, BC Carthon, MA Bilen, OA Abiodun-Ojo, AA Akintayo, VR Dhere, DM Schuster	05/22/2021
Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond. World journal of gastrointestinal oncology	M Elsayed, M Loya, J Galt, DM Schuster, ZL Bercu, J Newsome, D Brandon, S Benenati, K Behbahani, R Duszak, I Sethi, N Kokabi	05/15/2021
Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity? Clinical nuclear medicine	C Marcus, Y Baum, OA Abiodun-Ojo, AB Jani, DM Schuster	05/01/2021
Tumor-to-Normal Ratio Relationship between Planning Technetium-99 Macroaggregated Albumin and Posttherapy Yttrium-90 Bremsstrahlung SPECT/CT. Journal of vascular and interventional radiology : JVIR	A Villalobos, B Cheng, W Wagstaff, I Sethi, Z Bercu, DM Schuster, DC Brandon, J Galt, N Kokabi	05/01/2021
Role of ¹⁸F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review. AJR. American journal of roentgenology	B Savir-Baruch, PL Choyke, SP Rowe, DM Schuster, RM Subramaniam, H Jadvar	04/01/2021
Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT. Clinical nuclear medicine	A Baiomy, L Martiniova, E Efstathiou, DM Schuster, G Ravizzini	04/01/2021
Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer. Nuclear medicine communications	B Cheng, I Sethi, N Davisson, D Brandon, B Barron, J Galt, Z Bercu, DM Schuster, N Kokabi	04/01/2021
Using ¹⁸F-Fluciclovine PET/CT to Detect Prostate Cancer Recurrence in Patients With Very Low PSA Levels. AJR. American journal of roentgenology	BA Siegel, DM Schuster, B Savir-Baruch	03/01/2021
Comparison of Tc-99m MAA Planar Versus SPECT/CT Imaging for Lung Shunt Fraction Evaluation Prior to Y-90 Radioembolization: Are We Overestimating Lung Shunt Fraction? Cardiovascular and interventional radiology	M Elsayed, B Cheng, M Xing, I Sethi, D Brandon, DM Schuster, Z Bercu, J Galt, B Barron, N Kokabi	02/01/2021
Clinical utility of ¹⁸F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels. American journal of nuclear medicine and molecular imaging	C Marcus, OA Abiodun-Ojo, AB Jani, DM Schuster	01/01/2021
Exploratory study of ¹⁸F-fluciclovine pet/ct for response assessment to docetaxel in patients with metastatic castration-resistant prostate cancer. American journal of nuclear medicine and molecular imaging	AA Akintayo, MA Bilen, OA Abiodun-Ojo, O Kucuk, B Carthon, Z Chen, AB Jani, EE Parent, DM Schuster	01/01/2021
[¹⁸F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis. EJNMMI research	EE Parent, D Patel, JA Nye, Z Li, JJ Olson, DM Schuster, MM Goodman	12/07/2020
Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer. Clinical nuclear medicine	OA Abiodun-Ojo, AA Akintayo, GL Sica, M Alemozaffar, DM Schuster	12/01/2020
Initial Report of a Randomized Trial Comparing Conventional- vs Conventional plus Fluciclovine (¹⁸F) PET/CT Imaging-Guided Post-Prostatectomy Radiotherapy for Prostate Cancer. International journal of radiation oncology, biology, physics	A Jani, E Schreibmann, S Goyal, H Raghuveer, B Hershatter, PJ Rossi, JW Shelton, PR Patel, KM Xu, M Goodman, V Master, SS Joshi, O Kucuk, B Carthon, MA Bilen, S Cooper, B Fielder, O Abiodun-Ojo, VR Dhere, DM Schuster	12/01/2020
Erratum: Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. Seminars in interventional radiology	A Villalobos, MM Soliman, BS Majdalany, DM Schuster, J Galt, ZL Bercu, N Kokabi	12/01/2020
Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. Seminars in interventional radiology	A Villalobos, MM Soliman, BS Majdalany, DM Schuster, J Galt, ZL Bercu, N Kokabi	12/01/2020
ACR Appropriateness Criteria® Recurrent Lower Urinary Tract Infections in Females. Journal of the American College of Radiology : JACR	AM Venkatesan, A Oto, BC Allen, O Akin, LF Alexander, J Chong, AT Froemming, PF Fulgham, S Goldfarb, LM Gettle, JK Maranchie, BN Patel, N Schieda, DM Schuster, IB Turkbey, ME Lockhart	11/01/2020
[¹⁸F]Fluciclovine Positron Emission Tomography/Computerized Tomography for Preoperative Staging in Patients with Intermediate to High Risk Primary Prostate Cancer. The Journal of urology	M Alemozaffar, AA Akintayo, OA Abiodun-Ojo, D Patil, F Saeed, Y Huang, AO Osunkoya, MM Goodman, M Sanda, DM Schuster	10/01/2020
[¹⁸F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0. European journal of nuclear medicine and molecular imaging	C Nanni, L Zanoni, T Bach-Gansmo, H Minn, F Willoch, TV Bogsrud, EP Edward, B Savir-Baruch, E Teoh, F Ingram, S Fanti, DM Schuster	03/01/2020
Characterizing and Mitigating Bladder Radioactivity on ¹⁸F-Fluciclovine PET/CT. Journal of nuclear medicine technology	P Lovrec, DM Schuster, RH Wagner, M Gabriel, B Savir-Baruch	03/01/2020
Male pelvic multi-organ segmentation aided by CBCT-based synthetic MRI. Physics in medicine and biology	Y Lei, T Wang, S Tian, X Dong, AB Jani, D Schuster, WJ Curran, P Patel, T Liu, X Yang	02/04/2020
Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center. Clinical nuclear medicine	M Elsayed, RM Ermentrout, I Sethi, ZL Bercu, JR Galt, M Whitmore, DC Brandon, DM Schuster, N Kokabi	02/01/2020
¹⁸F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	OA Abiodun-Ojo, AA Akintayo, OO Akin-Akintayo, FI Tade, PT Nieh, VA Master, M Alemozaffar, AO Osunkoya, MM Goodman, B Fei, DM Schuster	11/01/2019
ACR Appropriateness Criteria® Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia. Journal of the American College of Radiology : JACR	LF Alexander, A Oto, BC Allen, O Akin, J Chong, AT Froemming, PF Fulgham, S Goldfarb, JK Maranchie, RN Mody, BN Patel, N Schieda, DM Schuster, IB Turkbey, AM Venkatesan, CL Wang, ME Lockhart	11/01/2019
Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer. AJR. American journal of roentgenology	B Savir-Baruch, P Lovrec, AA Solanki, WH Adams, PM Yonover, G Gupta, DM Schuster	10/01/2019
Role of novel imaging in the management of prostate cancer. Urologic oncology	KM Xu, RC Chen, DM Schuster, AB Jani	09/01/2019
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate Cancer. The Journal of urology	B Fei, OA Abiodun-Ojo, AA Akintayo, O Akin-Akintayo, F Tade, PT Nieh, VA Master, M Alemozaffar, AO Osunkoya, MM Goodman, DM Schuster	08/01/2019
Deep learning-based three-dimensional segmentation of the prostate on computed tomography images. Journal of medical imaging (Bellingham, Wash.)	M Shahedi, M Halicek, JD Dormer, DM Schuster, B Fei	04/01/2019
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [¹⁸F]FDG: version 1.0. European journal of nuclear medicine and molecular imaging	I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, C la Fougère, KJ Langen, E Lopci, V Lowe, J McConathy, HH Quick, B Sattler, DM Schuster, JC Tonn, M Weller	03/01/2019
A semiautomatic approach for prostate segmentation in MR images using local texture classification and statistical shape modeling. Proceedings of SPIE--the International Society for Optical Engineering	M Shahedi, M Halicek, Q Li, L Liu, Z Zhang, S Verma, DM Schuster, B Fei	02/01/2019
The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial. The Journal of urology	GL Andriole, L Kostakoglu, A Chau, F Duan, U Mahmood, DA Mankoff, DM Schuster, BA Siegel	02/01/2019
ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer. Clinical nuclear medicine	B Savir-Baruch, KP Banks, JE McConathy, OP Molchanova-Cook, EE Parent, A Takalkar, M Tulchinsky, JQ Yu, RM Subramaniam, DM Schuster	12/01/2018
Current Clinical Practice Patterns of Self-Identified Nuclear Medicine Specialists. AJR. American journal of roentgenology	P Balthazar, DM Schuster, EE Grady, AB Rosenkrantz, R Duszak	11/01/2018
Selective modification of fluciclovine (¹⁸F) transport in prostate carcinoma xenografts. Amino acids	FI Tade, WG Wiles, G Lu, B Bilir, O Akin-Akintayo, JS Lee, D Patil, W Yu, C Ormenisan Gherasim, B Fei, CS Moreno, AO Osunkoya, EJ Teoh, S Oka, H Okudaira, MM Goodman, DM Schuster	09/01/2018
Imaging of Prostate Cancer Using Fluciclovine. The Urologic clinics of North America	B Savir-Baruch, L Zanoni, DM Schuster	08/01/2018
[¹⁸F]Fluciclovine PET discrimination between high- and low-grade gliomas. EJNMMI research	EE Parent, M Benayoun, I Ibeanu, JJ Olson, CG Hadjipanayis, DJ Brat, V Adhikarla, J Nye, DM Schuster, MM Goodman	07/25/2018
Amino Acid Metabolism as a Target for Breast Cancer Imaging. PET clinics	GA Ulaner, DM Schuster	07/01/2018
A semiautomatic segmentation method for prostate in CT images using local texture classification and statistical shape modeling. Medical physics	M Shahedi, M Halicek, R Guo, G Zhang, DM Schuster, B Fei	06/01/2018
Prospective evaluation of fluciclovine (¹⁸F) PET-CT and MRI in detection of recurrent prostate cancer in non-prostatectomy patients. European journal of radiology	O Akin-Akintayo, F Tade, P Mittal, C Moreno, PT Nieh, P Rossi, D Patil, R Halkar, B Fei, V Master, AB Jani, H Kitajima, AO Osunkoya, C Ormenisan-Gherasim, MM Goodman, DM Schuster	05/01/2018
Update on ¹⁸F-Fluciclovine PET for Prostate Cancer Imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	EE Parent, DM Schuster	05/01/2018
ACR Appropriateness Criteria^® Post-treatment Follow-up Prostate Cancer. Journal of the American College of Radiology : JACR	AT Froemming, S Verma, SC Eberhardt, A Oto, LF Alexander, BC Allen, FV Coakley, BJ Davis, PF Fulgham, K Hosseinzadeh, C Porter, VA Sahni, DM Schuster, TN Showalter, AM Venkatesan, CL Wang, EM Remer	05/01/2018
ACR Appropriateness Criteria^® Pretreatment Staging of Muscle-Invasive Bladder Cancer. Journal of the American College of Radiology : JACR	CB van der Pol, VA Sahni, SC Eberhardt, A Oto, O Akin, LF Alexander, BC Allen, FV Coakley, AT Froemming, PF Fulgham, K Hosseinzadeh, JK Maranchie, RN Mody, N Schieda, DM Schuster, AM Venkatesan, CL Wang, ME Lockhart	05/01/2018
Bayesian penalised likelihood reconstruction (Q.Clear) of ¹⁸F-fluciclovine PET for imaging of recurrent prostate cancer: semi-quantitative and clinical evaluation. The British journal of radiology	EJ Teoh, DR McGowan, DM Schuster, MT Tsakok, FV Gleeson, KM Bradley	05/01/2018
⁹⁰Y radioembolization dosimetry using a simple semi-quantitative method in intrahepatic cholangiocarcinoma: Glass versus resin microspheres. Nuclear medicine and biology	N Nezami, N Kokabi, JC Camacho, DM Schuster, M Xing, HS Kim	04/01/2018
A semiautomatic algorithm for three-dimensional segmentation of the prostate on CT images using shape and local texture characteristics. Proceedings of SPIE--the International Society for Optical Engineering	M Shahedi, L Ma, M Halicek, R Guo, G Zhang, DM Schuster, P Nieh, V Master, B Fei	02/01/2018
A combined learning algorithm for prostate segmentation on 3D CT images. Medical physics	L Ma, R Guo, G Zhang, DM Schuster, B Fei	11/01/2017
PET Molecular Imaging-Directed Biopsy: A Review. AJR. American journal of roentgenology	B Fei, DM Schuster	08/01/2017
ACR Appropriateness Criteria^® Prostate Cancer-Pretreatment Detection, Surveillance, and Staging. Journal of the American College of Radiology : JACR	FV Coakley, A Oto, LF Alexander, BC Allen, BJ Davis, AT Froemming, PF Fulgham, K Hosseinzadeh, C Porter, VA Sahni, DM Schuster, TN Showalter, AM Venkatesan, S Verma, CL Wang, EM Remer, SC Eberhardt	05/01/2017
Fasting Enhances the Contrast of Bone Metastatic Lesions in ¹⁸F-Fluciclovine-PET: Preclinical Study Using a Rat Model of Mixed Osteolytic/Osteoblastic Bone Metastases. International journal of molecular sciences	S Oka, M Kanagawa, Y Doi, DM Schuster, MM Goodman, H Yoshimura	04/29/2017
Imaging of Prostate Cancer Using Fluciclovine. PET clinics	B Savir-Baruch, L Zanoni, DM Schuster	04/01/2017
Impact of ¹⁸F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	AB Jani, E Schreibmann, PJ Rossi, J Shelton, K Godette, P Nieh, VA Master, O Kucuk, M Goodman, R Halkar, S Cooper, Z Chen, DM Schuster	03/01/2017
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (¹⁸F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer. The Journal of urology	T Bach-Gansmo, C Nanni, PT Nieh, L Zanoni, TV Bogsrud, H Sletten, KA Korsan, J Kieboom, FI Tade, O Odewole, A Chau, P Ward, MM Goodman, S Fanti, DM Schuster, F Willoch	03/01/2017
Molecular imaging and fusion targeted biopsy of the prostate. Clinical and translational imaging	B Fei, PT Nieh, VA Master, Y Zhang, AO Osunkoya, DM Schuster	02/01/2017
Re: "Cost-Savings Analysis of Renal Scintigraphy, Stratified by Renal Function Thresholds: Mercaptoacetyltriglycine Versus Diethylene Triamine Penta-Acetic Acid". Journal of the American College of Radiology : JACR	AT Taylor, DM Schuster	02/01/2017
Automatic segmentation of the prostate on CT images using deep learning and multi-atlas fusion. Proceedings of SPIE--the International Society for Optical Engineering	L Ma, R Guo, G Zhang, F Tade, DM Schuster, P Nieh, V Master, B Fei	02/01/2017
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study. American journal of nuclear medicine and molecular imaging	AT Kendi, D Brandon, J Switchenko, JT Wadsworth, MW El-Deiry, NF Saba, DM Schuster, RM Subramaniam	01/01/2017
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer. Clinical nuclear medicine	OO Akin-Akintayo, AB Jani, O Odewole, FI Tade, PT Nieh, VA Master, LM Bellamy, RK Halkar, C Zhang, Z Chen, MM Goodman, DM Schuster	01/01/2017
Radionuclide Therapies in Molecular Imaging and Precision Medicine. PET clinics	AT Kendi, VM Moncayo, JA Nye, JR Galt, R Halkar, DM Schuster	01/01/2017
PET Tracer ¹⁸F-Fluciclovine Can Detect Histologically Proven Bone Metastatic Lesions: A Preclinical Study in Rat Osteolytic and Osteoblastic Bone Metastasis Models. Theranostics	S Oka, M Kanagawa, Y Doi, DM Schuster, MM Goodman, H Yoshimura	01/01/2017
PET Tracers Beyond FDG in Prostate Cancer. Seminars in nuclear medicine	DM Schuster, C Nanni, S Fanti	11/01/2016
Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	DM Schuster, C Nanni, S Fanti	10/01/2016
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors? AJR. American journal of roentgenology	AT Kendi, KR Magliocca, A Corey, JR Galt, J Switchenko, JT Wadsworth, MW El-Deiry, DM Schuster, NF Saba, PA Hudgins	09/01/2016
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT. European journal of nuclear medicine and molecular imaging	OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, PJ Rossi, RK Halkar, AO Osunkoya, O Akin-Akintayo, C Zhang, Z Chen, MM Goodman, DM Schuster	09/01/2016
Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. International journal of radiation oncology, biology, physics	E Schreibmann, DM Schuster, PJ Rossi, J Shelton, S Cooper, AB Jani	09/01/2016
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	FI Tade, MA Cohen, TM Styblo, OA Odewole, AI Holbrook, MS Newell, B Savir-Baruch, X Li, MM Goodman, JA Nye, DM Schuster	09/01/2016
Focal Hepatic Hot Spot From Superior Vena Cava Occlusion Visualized on Ventilation/Perfusion Scintigraphy With Contrast-Enhanced CT Correlate. Clinical nuclear medicine	M Lawrence, DM Schuster	05/01/2016
Combining Population and Patient-Specific Characteristics for Prostate Segmentation on 3D CT Images. Proceedings of SPIE--the International Society for Optical Engineering	L Ma, R Guo, Z Tian, R Venkataraman, S Sarkar, X Liu, F Tade, DM Schuster, B Fei	02/27/2016
Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images. Proceedings of SPIE--the International Society for Optical Engineering	L Ma, R Guo, Z Tian, R Venkataraman, S Sarkar, X Liu, PT Nieh, VV Master, DM Schuster, B Fei	02/27/2016
Is there a role for PET/CT parameters to differentiate thyroid cartilage invasion from penetration? European journal of radiology	AT Kendi, A Corey, KR Magliocca, JR Galt, C Zhang, Z Chen, K Higgins, JJ Beitler, JT Wadsworth, MW El-Deiry, DM Schuster, NF Saba, PA Hudgins	02/01/2016
90Y Radioembolization Lung Shunt Fraction in Primary and Metastatic Liver Cancer as a Biomarker for Survival. Clinical nuclear medicine	M Xing, S Lahti, N Kokabi, DM Schuster, JC Camacho, HS Kim	01/01/2016
[(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells. Nuclear medicine and biology	M Ono, S Oka, H Okudaira, T Nakanishi, A Mizokami, M Kobayashi, DM Schuster, MM Goodman, Y Shirakami, K Kawai	11/01/2015
Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach. Annals of surgical oncology	MH Squires, N Volkan Adsay, DM Schuster, MC Russell, K Cardona, KA Delman, JH Winer, D Altinel, JM Sarmiento, B El-Rayes, N Hawk, CA Staley, SK Maithel, DA Kooby	07/01/2015
The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care. Academic radiology	VM Moncayo, KE Applegate, R Duszak, BJ Barron, J Fitz, RK Halkar, DJ Lee, DM Schuster	06/01/2015
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers? European journal of radiology	AT Kendi, A Corey, KR Magliocca, DC Nickleach, J Galt, JM Switchenko, MW El-Deiry, JT Wadsworth, PA Hudgins, NF Saba, DM Schuster	06/01/2015
Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nature methods	PJ Santangelo, KA Rogers, C Zurla, EL Blanchard, S Gumber, K Strait, F Connor-Stroud, DM Schuster, PK Amancha, JJ Hong, SN Byrareddy, JA Hoxie, B Vidakovic, AA Ansari, E Hunter, F Villinger	05/01/2015
Reproducibility and reliability of anti-3-[¹⁸F]FACBC uptake measurements in background structures and malignant lesions on follow-up PET-CT in prostate carcinoma: an exploratory analysis. Molecular imaging and biology	OA Odewole, OA Oyenuga, F Tade, B Savir-Baruch, PT Nieh, V Master, Z Chen, X Wang, AB Jani, LM Bellamy, RK Halkar, MM Goodman, DM Schuster	04/01/2015
Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status? Clinical nuclear medicine	AT Kendi, K Magliocca, A Corey, DC Nickleach, J Galt, K Higgins, JJ Beitler, MW El-Deiry, JT Wadsworth, PA Hudgins, NF Saba, DM Schuster	03/01/2015
(90)Y Radioembolization: Multimodality Imaging Pattern Approach with Angiographic Correlation for Optimized Target Therapy Delivery. Radiographics : a review publication of the Radiological Society of North America, Inc	JC Camacho, V Moncayo, N Kokabi, HE Reavey, JR Galt, K Yamada, DD Kies, RS Williams, HS Kim, DM Schuster	01/01/2015
Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine	DM Schuster, C Nanni, S Fanti, S Oka, H Okudaira, Y Inoue, J Sörensen, R Owenius, P Choyke, B Turkbey, TV Bogsrud, T Bach-Gansmo, RK Halkar, JA Nye, OA Odewole, B Savir-Baruch, MM Goodman	12/01/2014
PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma. Clinical nuclear medicine	JC Camacho, N Kokabi, M Xing, DM Schuster, HS Kim	11/01/2014
A rare presentation of myocardial plasmacytoma assessed by FDG PET/CT. Clinical nuclear medicine	AK Tong, KP Mann, DM Schuster, X Yan	07/01/2014
Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Molecular imaging and biology	S Oka, H Okudaira, M Ono, DM Schuster, MM Goodman, K Kawai, Y Shirakami	06/01/2014
Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial. The Journal of urology	DM Schuster, PT Nieh, AB Jani, R Amzat, FD Bowman, RK Halkar, VA Master, JA Nye, OA Odewole, AO Osunkoya, B Savir-Baruch, P Alaei-Taleghani, MM Goodman	05/01/2014
A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Journal of vascular and interventional radiology : JVIR	N Kokabi, JR Galt, M Xing, JC Camacho, BJ Barron, DM Schuster, HS Kim	02/01/2014
Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma. Journal of vascular and interventional radiology : JVIR	BR Eaton, HS Kim, E Schreibmann, DM Schuster, JR Galt, B Barron, S Kim, Y Liu, J Landry, T Fox	02/01/2014
Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy. Annals of surgical oncology	BR Eaton, A Losken, D Okwan-Duodu, DM Schuster, JM Switchenko, D Mister, K Godette, MA Torres	01/01/2014
Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines. Brain research	M Ono, S Oka, H Okudaira, DM Schuster, MM Goodman, K Kawai, Y Shirakami	10/16/2013
Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions. Molecular imaging and biology	R Amzat, P Taleghani, DL Miller, JJ Beitler, LM Bellamy, JA Nye, W Yu, B Savir-Baruch, AO Osunkoya, Z Chen, WF Auffermann, MM Goodman, DM Schuster	10/01/2013
Differences in neural activation for object-directed grasping in chimpanzees and humans. The Journal of neuroscience : the official journal of the Society for Neuroscience	EE Hecht, LE Murphy, DA Gutman, JR Votaw, DM Schuster, TM Preuss, GA Orban, D Stout, LA Parr	08/28/2013
Imaging quality of F-18-FDG PET/CT in the inpatient versus outpatient setting. Annals of nuclear medicine	X Yan, J Kang, Y Zhou, R Ehsan, R Halkar, KE Applegate, DM Schuster	07/01/2013
Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Nuclear medicine and biology	H Okudaira, T Nakanishi, S Oka, M Kobayashi, H Tamagami, DM Schuster, MM Goodman, Y Shirakami, I Tamai, K Kawai	07/01/2013
Accuracy Evaluation of a 3D Ultrasound-guided Biopsy System. Proceedings of SPIE--the International Society for Optical Engineering	WJ Wooten, JA Nye, DM Schuster, PT Nieh, VA Master, JR Votaw, B Fei	03/14/2013
Radiation field design and patterns of locoregional recurrence following definitive radiotherapy for breast cancer. International journal of radiation oncology, biology, physics	SA Chen, DM Schuster, D Mister, T Liu, K Godette, MA Torres	02/01/2013
Characterization of primary prostate carcinoma by anti-1-amino-2-[(18)F] -fluorocyclobutane-1-carboxylic acid (anti-3-[(18)F] FACBC) uptake. American journal of nuclear medicine and molecular imaging	DM Schuster, PA Taleghani, PT Nieh, VA Master, R Amzat, B Savir-Baruch, RK Halkar, T Fox, AO Osunkoya, CS Moreno, JA Nye, W Yu, B Fei, Z Wang, Z Chen, MM Goodman	01/01/2013
PET-directed, 3D Ultrasound-guided prostate biopsy. Diagnostic imaging Europe	B Fei, PT Nieh, DM Schuster, VA Master	01/01/2013
Hyperspectral imaging and quantitative analysis for prostate cancer detection. Journal of biomedical optics	H Akbari, LV Halig, DM Schuster, A Osunkoya, V Master, PT Nieh, GZ Chen, B Fei	07/01/2012
Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization. Journal of vascular and interventional radiology : JVIR	SM Piduru, DM Schuster, BJ Barron, R Dhanasekaran, DH Lawson, HS Kim	07/01/2012
Heme products post-radiofrequency ablation obscure tumor recurrence on MR but not on PET-CT. Nuclear medicine and molecular imaging	SR Ehsan, CE Gooden, DM Schuster	06/01/2012
Metastatic Breast Lesion to the Falx Detected with PET-CT. Nuclear medicine and molecular imaging	C Harrison, DM Schuster	06/01/2012
¹¹¹In OctreoScan SPECT-MRI fusion for the detection of a pancreatic insulinoma. Clinical nuclear medicine	VM Moncayo, DR Martin, JM Sarmiento, B Zbytek, T Fox, DM Schuster	03/01/2012
Transport mechanisms of trans-1-amino-3-fluoro[1-(14)C]cyclobutanecarboxylic acid in prostate cancer cells. Nuclear medicine and biology	S Oka, H Okudaira, Y Yoshida, DM Schuster, MM Goodman, Y Shirakami	01/01/2012
A Molecular Image-directed, 3D Ultrasound-guided Biopsy System for the Prostate. Proceedings of SPIE--the International Society for Optical Engineering	B Fei, DM Schuster, V Master, H Akbari, A Fenster, P Nieh	01/01/2012
Pilot evaluation of anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma. Molecular imaging and biology	B Savir-Baruch, DM Schuster, N Jarkas, VA Master, PT Nieh, RK Halkar, JA Nye, MM Lewis, RJ Crowe, RJ Voll, VM Camp, LM Bellamy, DL Roberts, MM Goodman	12/01/2011
Incremental benefit of SPECT + CT bone scans over conventional planar and SPECT bone scans in vertebroplasty. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India	K Kumar, RK Halkar, SC Bartley, DM Schuster	10/01/2011
Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid. Nuclear medicine and biology	JA Nye, N Jarkas, DM Schuster, B Savir-Baruch, RJ Voll, VM Camp, MM Goodman	10/01/2011
Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT. Clinical nuclear medicine	R Amzat, P Taleghani, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, MM Lewis, M Faurot, LM Bellamy, MM Goodman, DM Schuster	09/01/2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CT. Radiology	DM Schuster, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, PJ Rossi, MM Lewis, JA Nye, W Yu, FD Bowman, MM Goodman	06/01/2011
Absent coronary artery calcium excludes inducible myocardial ischemia on computed tomography/positron emission tomography. International journal of cardiology	FP Esteves, A Khan, LC Correia, JA Nye, RK Halkar, DM Schuster, A Stillman, P Raggi	03/17/2011
Automatic 3D Segmentation of Ultrasound Images Using Atlas Registration and Statistical Texture Prior. Proceedings of SPIE--the International Society for Optical Engineering	X Yang, D Schuster, V Master, P Nieh, A Fenster, B Fei	01/01/2011
A PET/CT Directed, 3D Ultrasound-Guided Biopsy System for Prostate Cancer. Prostate cancer imaging : image analysis and image-guided interventions : international workshop held in conjunction with MICCAI 2011, Toronto, Canada, September 22, 2011 : proceedings	B Fei, V Master, P Nieh, H Akbari, X Yang, A Fenster, D Schuster	01/01/2011
Posterior bladder layering of excreted 18F-FDG on PET/CT. Nuclear medicine communications	W Zeng, JN Sepulveda, J Nye, JR Votaw, PT Nieh, J Carew, DM Schuster	10/01/2010
MR-based attenuation correction for hybrid PET-MR brain imaging systems using deformable image registration. Medical physics	E Schreibmann, JA Nye, DM Schuster, DR Martin, J Votaw, T Fox	05/01/2010
Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology	FP Esteves, JA Nye, A Khan, RD Folks, RK Halkar, EV Garcia, DM Schuster, S Lerakis, P Raggi, JR Votaw	04/01/2010
Breast angiosarcoma: FDG PET findings. Clinical nuclear medicine	W Zeng, TM Styblo, S Li, JN Sepulveda, DM Schuster	07/01/2009
Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design. Clinical nuclear medicine	AB Jani, TH Fox, D Whitaker, DM Schuster	05/01/2009
Initial experience with the radiotracer anti-1-amino-3-[18F]Fluorocyclobutane-1-carboxylic acid (anti-[ 18F]FACBC) with PET in renal carcinoma. Molecular imaging and biology	DM Schuster, JA Nye, PT Nieh, JR Votaw, RK Halkar, MM Issa, W Yu, J Sepulveda, W Zeng, A Young, MM Goodman	01/01/2009
Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress. Molecular imaging and biology	DM Schuster, RK Halkar, FP Esteves, EV Garcia, CD Cooke, MA Syed, FD Bowman, JR Votaw	01/01/2008

Ratings & Reviews

Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.